Three surgeons operating on patient in the OR

About MEI


Mission Statement

Medical Engineering Innovations, Inc. is dedicated to the development and commercialization of electro-mechanical medical devices that provide better surgical tools to meet unmet needs, advance patient care, quality of life and healthcare cost-effectiveness.

Our Company

MEI is focused on bringing new technologies to market that combat liver cancer with more effective tools for liver surgery and localized cancer treatment by heat (tumor ablation). Our technologies combine a proprietary algorithm to control the application of radiofrequency energy to tissue, with enhanced blade electrode geometries to optimize tissue heating. MEI was founded in October 2005 in Madison, Wisconsin by:

  • John Webster Emeritus Professor, University of Wisconsin-Madison, Biomedical Engineering
  • James Will Emeritus Professor, University of Wisconsin-Madison, Animal Health and Biomedical Sciences
  • David Mahvi Professor, Northwestern Medical School, Dept. of Surgery, formerly at UW SMPH
  • Dieter Haemmerich Associate Professor, Medical University of South Carolina, Department of Pediatrics; Clemson University, Department of Bioengineering
  • David Schutt Research Specialist, Medical University of South Carolina, Department of Pediatrics
  • Ann O’Rourke Senior Surgical Resident, UW Medical School, Dept. Surgery

Bringing a wealth of business, product development and commercialization experience to the MEI team, 2012 saw the addition of:

History & Milestones

2005
•  Company founded
2006
•  Animal Testing Benchmark Devices
•  Patents Filed
2007
•  Applied for SBIR Phase 1
•  Continued Animal Testing and Software Development
2008
•  Received Phase 1 NIH grant support for resection device, $100k
•  US Patent #7,367,974 issued
•  Initiated development of prototype RF generator
2009
•  Testing of resection electrode array (SwiftBlade™-R)
•  Achieved clinical milestone of sealing all vessels (which were up to 5 mm diameter) in live animal testing
•  Received Phase 1 NIH grant support for circumferential device, $100k
•  Business Plan Filed with Wisconsin Alumni Research Foundation (WARF)
2010
•  Testing of prototype RF generator
2011
•  Formalize Business Plan
•  Proposals for development of clinical device from potential development partners •  Animal trials with ablation circumferential electrode array (SwiftBlade™-A)
2012
•  CEO hired to drive commercialization and fund raising
•  Exclusive patent license agreement finalized
•  Select and initiate work with development partner
2013
•  Development of RF generator clinical prototype started
•  Select manufacturing partners
•  Implement Quality Management System
2014
•  SwiftBlade™-R clinical prototype handset development started
•  Patent protection extended to Germany, France and Italy
•  Phase-2 SBIR grant awarded
2015
•  WEDC/CTC “SBIR Advance” grant awarded
• Created product family logo
2016
•  P2 RF Generator tested on ex vivo tissue
•  First pig survival surgery”
2017
•  Anticipated FDA 510(k) submission
•  Anticipated ISO 13485 certification audit
•  Anticipated first product launch